CBD for ADHD & Focus: A Natural Alternative in Malta?
With ADHD diagnoses rising in Malta, many are looking for non-stimulant alternatives. We explore the research on CBD for focus, hyperactivity, and executive dysfunction.
Attention Deficit Hyperactivity Disorder (ADHD) diagnoses in adults are on the rise in Malta. While stimulant medications like Ritalin or Concerta are the standard treatment, many people experience unwanted side effects like jitters, insomnia, or "crashes". This has led to a surge of interest in CBD as a natural, non-stimulant tool for managing the "noise" of a neurodivergent brain.
🧠 Dopamine & The Brain
ADHD is often linked to a deficiency in dopamine. While CBD does not stimulate dopamine release directly like amphetamines, it interacts with the brain's adenosine andserotonin receptors. This can arguably improve "executive function" by reducing the background anxiety and racing thoughts that cause distraction.
Is CBD a Stimulant?
No. CBD is not a stimulant. It will not give you a "buzz" or forced energy. Instead, users with ADHD often describe the effect as "quieting the internal monologue." When the anxiety of "what do I have to do next?" is silenced, focus becomes easier to maintain naturally.
The "Secondary Symptoms" Strategy
Often, the most debilitating parts of ADHD are not the lack of focus itself, but the secondary symptoms:
- Insomnia: Racing thoughts keeping you awake at 2 AM.
- RSD (Rejection Sensitive Dysphoria): Intense emotional pain from perceived rejection.
- Sensory Overload: Feeling overwhelmed by lights/sounds (e.g., Paceville crowds).
CBD is scientifically proven to help with these specific secondary issues, indirectly leading to a better quality of life and improved ability to work.
Full Spectrum vs Isolate for Focus
For ADHD, most experts recommend Broad Spectrum or Isolate (THC-Free) during the day to avoid any potential grogginess. However, for evening wind-down, a Full Spectrum oil helps engage the "rest and digest" system.
📚 Scientific References
- ADHD & Cannabinoids: Cooper, R. E., et al. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795-808.
- Anxiety Reduction: Blessing, E. M., et al. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics, 12(4), 825–836.
Recommended by Dr. Vella
About Dr. Marija Vella
Dr. Marija Vella is a Ph.D. Pharmacologist and our Head of Quality Assurance. She ensures all CBD Malta products meet rigorous pharmaceutical standards and provides evidence-based guidance on cannabinoid wellness.
Read full bio →
